CORNING PHARMACEUTICAL SERVICES INC. – Trademark Portfolio
Entity Type: 03
CORNING PHARMACEUTICAL SERVICES INC. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 3 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include COVANCE. The owner is based in Princeton, NJ.
210 Carnegie Center
Princeton, NJ 085406233
Showing of trademarks Trademarks
Trademark Classifications
CORNING PHARMACEUTICAL SERVICES INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does CORNING PHARMACEUTICAL SERVICES INC. have?
CORNING PHARMACEUTICAL SERVICES INC. has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 cancelled.
What trademark classes does CORNING PHARMACEUTICAL SERVICES INC. file in?
CORNING PHARMACEUTICAL SERVICES INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 35 (Advertising & Business). Class 42 covers scientific and technological services; industrial analysis and research services.
What are CORNING PHARMACEUTICAL SERVICES INC.'s most well-known trademarks?
CORNING PHARMACEUTICAL SERVICES INC.'s registered trademark portfolio includes well-known marks such as COVANCE. These are among 2 currently registered trademarks in the portfolio.
What is CORNING PHARMACEUTICAL SERVICES INC.'s trademark registration success rate?
CORNING PHARMACEUTICAL SERVICES INC. has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.